Certified by Founder Lodge
Johnson & Johnson
United States - New Brunswick, NJ
INVESTOR
1 Disclosed Funding Rounds $25,000,000
28 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Profound Change Requires Boldness.
Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have
Company | Date | Round | Raised |
---|---|---|---|
Causaly | July, 14 ,2023 | Series B | $60,000,000 |
MedCrypt | November, 02 ,2022 | Series B | $25,000,000 |
Arialys Therapeutics, Inc. | September, 13 ,2023 | Seed | $58,000,000 |
Moon Surgical | June, 30 ,2022 | Series A | $31,300,000 |
SwipeRx | May, 23 ,2022 | Series B | $27,000,000 |
Osteal Therapeutics | September, 26 ,2023 | Series C | $23,000,000 |
Rapport Therapeutics | March, 08 ,2023 | Series A | $100,000,000 |
RefleXion Medical | November, 17 ,2023 | Unknown | $105,000,000 |
ArteraAI | March, 27 ,2023 | Unknown | $90,000,000 |
Health In Her HUE | January, 09 ,2024 | Unknown | $3,000,000 |
Solenic Medical | June, 21 ,2023 | Series A | $5,100,000 |
FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
Causaly | July, 14 ,2023 | Series B | $60,000,000 |
Tempo Therapeutics | March, 21 ,2024 | Series A | $12,000,000 |
Arialys Therapeutics, Inc. | September, 13 ,2023 | Seed | $58,000,000 |
HistoSonics, Inc. | August, 16 ,2024 | Series D | $102,000,000 |
Osteal Therapeutics | September, 26 ,2023 | Series C | $23,000,000 |
SpectraWAVE, Inc. | September, 12 ,2024 | Series B | $50,000,000 |
RefleXion Medical | November, 17 ,2023 | Unknown | $105,000,000 |
ONL Therapeutics | September, 17 ,2024 | Series D | $65,000,000 |
Health In Her HUE | January, 09 ,2024 | Unknown | $3,000,000 |
TRexBio | November, 14 ,2024 | Series B | $84,000,000 |
FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
Tempo Therapeutics | March, 21 ,2024 | Series A | $12,000,000 |
HistoSonics, Inc. | August, 16 ,2024 | Series D | $102,000,000 |
SpectraWAVE, Inc. | September, 12 ,2024 | Series B | $50,000,000 |
ONL Therapeutics | September, 17 ,2024 | Series D | $65,000,000 |
TRexBio | November, 14 ,2024 | Series B | $84,000,000 |